Protalix BioTherapeutics (PLX) Inventory (2010 - 2026)
Protalix BioTherapeutics (PLX) posted quarterly Inventory of $30.5 million for Q1 2026, up 56.23% year-over-year from $19.5 million in Q1 2025, and up 18.44% quarter-over-quarter from $25.7 million in Q4 2025.
Protalix BioTherapeutics (PLX) Inventory (2010 - 2026) Analysis & Trends
Protalix BioTherapeutics' Inventory history runs 17 years deep, the most recent figure standing at $30.5 million for Q1 2026.
- In Q1 2026, Inventory rose 56.23% year-over-year to $30.5 million; the TTM figure through Mar 2026 stood at $30.5 million (up 56.23% YoY), while the FY2025 annual figure was $25.7 million, up 21.12% from the prior year.
- Inventory for Q1 2026 stood at $30.5 million, up from $25.7 million in the prior quarter.
- The five-year high for Inventory was $30.5 million in Q1 2026, with the low at $14.6 million in Q3 2022.
- The 5-year median for Inventory is $20.3 million (2023), against an average of $20.3 million.
- The sharpest annual moves came in 2024 and 2026: Inventory fell 20.31% in 2024, then jumped 56.23% in 2026.
- Protalix BioTherapeutics' Inventory stood at $16.8 million in 2022, then advanced by 13.34% to $19.0 million in 2023, then advanced by 11.54% to $21.2 million in 2024, then advanced by 21.12% to $25.7 million in 2025, then rose by 18.44% to $30.5 million in 2026.
- Business Quant data shows PLX's Inventory at $30.5 million in Q1 2026, $25.7 million in Q4 2025, and $21.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 97.11 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 142.38 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 128.86 Mn |
| 10 | Protalix BioTherapeutics | 190.37 Mn | 149.71 Mn | 12.13 Mn | 32.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.29 Mn |
| Mar 31, 2026 | 30.47 Mn |
| Dec 31, 2025 | 25.73 Mn |
| Sep 30, 2025 | 21.26 Mn |
| Jun 30, 2025 | 21.13 Mn |
| Mar 31, 2025 | 19.51 Mn |
| Dec 31, 2024 | 21.24 Mn |
| Sep 30, 2024 | 17.20 Mn |
| Jun 30, 2024 | 20.72 Mn |
| Mar 31, 2024 | 22.35 Mn |
| Dec 31, 2023 | 19.05 Mn |
| Sep 30, 2023 | 21.58 Mn |
| Jun 30, 2023 | 19.64 Mn |
| Mar 31, 2023 | 20.30 Mn |
| Dec 31, 2022 | 16.80 Mn |
| Sep 30, 2022 | 14.56 Mn |
| Jun 30, 2022 | 16.51 Mn |
| Mar 31, 2022 | 16.59 Mn |
| Dec 31, 2021 | 17.95 Mn |
| Sep 30, 2021 | 14.73 Mn |